<?xml version="1.0" encoding="UTF-8"?>
<feed xmlns="http://www.w3.org/2005/Atom">
  <id>https://recalls.watch/feed/substance-fenofibrate.xml</id>
  <title>Recalls Watch: Fenofibrate</title>
  <link rel="self" href="https://recalls.watch/feed/substance-fenofibrate.xml"/>
  <link href="https://recalls.watch/alerts/"/>
  <updated>2026-07-01T00:00:00Z</updated>
  <entry>
    <id>https://recalls.watch/recall/fda/99130/</id>
    <title>Ajanta Pharma USA Inc: Fenofibrate Capsules</title>
    <link href="https://recalls.watch/recall/fda/99130/"/>
    <updated>2026-07-01T12:00:00Z</updated>
    <category term="drugs"/>
    <summary>FDA: CGMP Deviations</summary>
  </entry>
  <entry>
    <id>https://recalls.watch/recall/fda/96474/</id>
    <title>Glenmark Pharmaceuticals Inc., USA: Fenofibrate Capsules 67 mg and 38 more</title>
    <link href="https://recalls.watch/recall/fda/96474/"/>
    <updated>2025-04-16T12:00:00Z</updated>
    <category term="drugs"/>
    <summary>FDA: CGMP Deviations</summary>
  </entry>
</feed>
